Generic · Extended-release capsule
Methylphenidate 15 mg extended-release capsule price what pharmacies pay, and what you should
There is no weekly pharmacy acquisition cost for methylphenidate 15 mg extended-release capsule this week. The makers, package codes, recalls and label are below.
What people paid for methylphenidate 15 mg extended-release capsule
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)
- Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)Allocation to current contracted customers
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)
- Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)
- Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)Temporary discontinuation of 100ct
- Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)Temporary discontinuation of 100ct
- Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)Allocation to current contracted customers
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)Allocation to current contracted customers
- Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)Allocation to current contracted customers
- Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 66 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
2 companies sell methylphenidate 15 mg extended-release capsule under 2 package codes (NDCs).
| Maker | Package codes | Per unit |
|---|---|---|
| Actavis Pharma, Inc. | 0591-3862-19 | - |
| Rhodes Pharmaceuticals LLC | 42858-076-45 | - |
All 2 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Other methylphenidate strengths and forms
Official label & what changed
These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES.METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CIIInitial U.S. Approval: 1955
WARNING: ABUSE, MISUSE, AND ADDICTION
Methylphenidate hydrochloride extended-release has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including methylphenidate hydrochloride extended-release, can result in overdose and death [see Overdosage (10)], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.
Before prescribing methylphenidate hydrochloride extended-release, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout methylphenidate hydrochloride extended-release treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction [see Warnings and Precautions (5.1) and Drug Abuse and Dependence (9.2)].
WARNING: ABUSE, MISUSE, AND ADDICTION
See full prescribing information for complete boxed warning.
Methylphenidate hydrochloride extended-release has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including methylphenidate hydrochloride extended-release, can result in overdose and death (5.1, 9.2, 10):
Before prescribing methylphenidate hydrochloride extended-release, assess each patient's risk for abuse, misuse, and addiction.
Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.
Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
Recent major changes (as listed on the label)
RECENT MAJOR CHANGES
Indications and Usage (1) 09/2025
Warnings and Precautions (5.7) 09/2025
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about methylphenidate 15 mg extended-release capsule
Who makes methylphenidate 15 mg extended-release capsule?
2 companies: Actavis Pharma, Inc., Rhodes Pharmaceuticals LLC. See every package code.
Is methylphenidate in shortage?
Yes - 38 products are listed as short or being discontinued. Details.
Has methylphenidate been recalled?
66 recalls on record, 1 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about methylphenidate 15 mg extended-release capsule
No comments yet. Questions, tips, what worked for you - start the conversation.